| アブストラクト | INTRODUCTION: Elevated international normalized ratio (INR) has been commonly reported as an adverse drug event (ADE) for patients taking warfarin for anticoagulant therapy. AIM: The purpose of this study was to determine the association between increased INR and the usage of warfarin by using the pharmacovigilance data from the FDA Adverse Event Reporting System (FAERS). METHODS: The ADEs in patients who took warfarin (N = 77,010) were analyzed using FAERS data. Association rule mining was applied to identify warfarin-related ADEs that were most associated with elevated INR (n = 15,091) as well as possible drug-drug interactions (DDIs) associated with increased INR. Lift values were used to identify ADEs that were most commonly reported alongside elevated INR based on the correlation between both item sets. In addition, this study sought to determine if the increased INR risk was influenced by sex, age, temporal distribution, and geographic distribution and were reported as reporting odds ratios (RORs). RESULTS: The top 5 ADEs most associated with increased INR in patients taking warfarin were decreased hemoglobin (lift = 2.31), drug interactions (lift = 1.88), hematuria (lift = 1.58), asthenia (lift = 1.44), and fall (lift = 1.32). INR risk increased as age increased, with individuals older than 80 having a 63% greater likelihood of elevated INR compared to those younger than 50. Males were 9% more likely to report increased INR as an ADE compared to females. Individuals taking warfarin concomitantly with at least one other drug were 43% more likely to report increased INR. The top 5 most frequently identified DDIs in patients taking warfarin and presenting with elevated INR were acetaminophen (lift = 1.81), ramipril (lift = 1.71), furosemide (lift = 1.64), bisoprolol (lift = 1.58), and simvastatin (lift = 1.58). CONCLUSION: The risk of elevated INR increased as patient age increased, particularly among those older than 80. Elevated INR frequently co-presented with decreased hemoglobin, drug interactions, hematuria, asthenia, and fall in patients taking warfarin. This effect may be less pronounced in women due to the procoagulatory effects of estrogen signaling. Multiple possible DDIs were identified, including acetaminophen, ramipril, and furosemide. |
|---|
| ジャーナル名 | The journal of cardiovascular aging |
|---|
| Pubmed追加日 | 2024/1/18 |
|---|
| 投稿者 | Morris, Robert; Todd, Megan; Aponte, Nicole Zapata; Salcedo, Milagros; Bruckner, Matthew; Garcia, Alfredo Suarez; Webb, Rachel; Bu, Kun; Han, Weiru; Cheng, Feng |
|---|
| 組織名 | Department of Pharmaceutical Sciences, Taneja College of Pharmacy, University of;South Florida, Tampa, FL 33612, USA.;Department of Biostatistics and Epidemiology, College of Public Health,;University of South Florida, Tampa, FL 33612, USA.;Department of Mathematics & Statistics, College of Art and Science, University of;South Florida, Tampa, FL 33620, USA. |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/38235056/ |
|---|
